AGENDA

Friday, March 11, 2022

7:00 AM

Industry-Sponsored Event (Non-Accredited)

Hepatitis D Virus Infection: Epidemiology, Pathophysiology, and Clinical Management

Session II: Cholestatic Liver Disease & Chronic Liver Disease from Childhood

to Adulthood

Part I: Cholestatic Liver Disease

Moderator: Kimberly Brown, MD

10:30 AM

Primary Biliary Cholangitis: Practice Updates and New Treatments in Development

Kris Kowdley, MD

10:50 AM

Stop the Itch! Managing Pruritus in Children and Adults with Cholestatic Liver Disease

Cynthia Levy, MD

11:10 AM

Case: Differential Diagnosis of Inherited

Cholestatic Disorders

Naim Alkhouri, MD

11:20 AM

Q&A / Panel Discussion

Part II: Chronic Liver Disease from Childhood
to Adulthood

Moderators: Kimberly Brown, MD and Miriam Vos, MD, MSPH

11:30 AM

Wilson Disease: Diagnosis and Management Across the Age Spectrum

Kris Kowdley, MD

11:50 AM

Minding the Gap: Transitioning the Adolescent with Chronic Liver Disease Into an Adult Practice

Nitika Gupta, MD

12:10 PM

Case: Transition of Care

Naim Alkhouri, MD and Miriam Vos, MD, MSPH

12:20 PM

Q&A / Panel Discussion

12:30 PM

Lunch Break

12:45 PM

CLDF Lunch Independent Symposium (Accredited)

Expert Insights: On the Use of Albumin in
Cirrhotic Patients

Sammy Saab, MD, MPH, and Marcelo Kugelmas, MD

Saturday, March 12, 2022

7:15 AM

Industry-Sponsored Event (Non-Accredited)

Taking Current PBC Treatment Further
Sponsored by: Intercept Pharmaceuticals, Inc.

Robert Brown, MD, MPH

8:00 AM

Break

8:30 AM

Welcome Back

Zobair Younossi, MD, MPH

Session III: NASH

Moderator: Zobair Younossi, MD, MPH

Part I

8:30 AM

NASH Awareness and Burden of Disease

Zobair Younossi, MD, MPH

8:40 AM

Interactive Panel Discussion

Panelists:

Alina Allen, MD; Kathleen Corey, MD, MPH;
Scott Isaacs, MD; and Zobair Younossi, MD, MPH

Part II

9:00 AM

Diagnostic and Prognostic Non-Invasive Tests

Mazen Noureddin, MD, MHSc

9:10 AM

Interactive Panel Discussion

Panelists:

Scott Friedman, MD; Scott Isaacs, MD; Rohit Loomba, MD, MHSc; Mazen Noureddin, MD, MHSc; and

Zobair Younossi, MD, MPH

Part III

9:30 AM

Treatment: How Do We Treat Today, Tomorrow and in the Future?

Stephen Harrison, MD

9:40 AM

Interactive Panel Discussion

Panelists:

Manal Abdelmalek, MD, MPH; Naim Alkhouri, MD;

Stephen Harrison, MD; and Zobair Younossi, MD, MPH

10:00 AM

Break

Session IV: Complications of Cirrhosis &

Portal Hypertension

Moderators: Aijaz Ahmed, MD; Steven Flamm, MD; and Sammy Saab, MD, MPH

10:30 AM

Evaluating Patients for Covert Encephalopathy

and Management

Jasmohan Bajaj, MD

10:50 AM

Experience with Liver Transplant for Alcohol Hepatitis: Lessons Learned

Haripriya Maddur, MD

11:10 AM

TIPS: When is the Appropriate Time to Use?

Justin Boike, MD, MPH

11:30 AM

HCC: New Approaches to Management

Laura Kulik, MD

11:50 AM

Treating HRS: Do the Benefits Outweigh the Risks?

Treat: Steven Flamm, MD

Don't Treat: Robert Wong, MD

12:10 PM

Q&A / Panel Discussion

12:30 PM

Liver Connect Summary and Beyond!

Kimberly Brown, MD

12:45 PM

Lunch | CLDF Independent Symposium (Accredited)

Recognizing Hepatitis D (HDV): Epidemiology, Virology, Tests and Treatment Options

Robert Gish, MD and Tatyana Kushner, MD, MSCE

1:45 PM

Adjourn

This activity is supported by an educational grant from AbbVie, Gilead Sciences, Intercept Pharmaceuticals, Inc.,
Ipsen Innovation S.A.S., Madrigal Pharmaceuticals, Mallinckrodt Pharmaceuticals and Salix Pharmaceuticals.

Accredited by

Presented by